Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis

Liver fibrosis, a consequence of chronic liver injury and a way station to cirrhosis and hepatocellular carcinoma, lacks effective treatment. Endocannabinoids acting via cannabinoid-1 receptors (CB(1)R) induce profibrotic gene expression and promote pathologies that predispose to liver fibrosis. CB(...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JCI Insight
Auteurs principaux: Cinar, Resat, Iyer, Malliga R., Liu, Ziyi, Cao, Zongxian, Jourdan, Tony, Erdelyi, Katalin, Godlewski, Grzegorz, Szanda, Gergő, Liu, Jie, Park, Joshua K., Mukhopadhyay, Bani, Rosenberg, Avi Z., Liow, Jeih-San, Lorenz, Robin G., Pacher, Pal, Innis, Robert B., Kunos, George
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
https://ncbi.nlm.nih.gov/pubmed/27525312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.87336
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires